PM

Paul McEwan

North America, New York, United States, New York

Description

Paul is a co–founder and currently serves as the Chief Scientific Officer of Kapa Biosystems, a company using protein evolution technology f...

Investor Profile

Paul McEwan has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Analytics
  • Biopharma
  • Health Diagnostics
  • Pharmaceutical
  • Biometrics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Paul McEwan frequently co-invest with?

BroadOak Capital Partners
North America, Maryland, United States, Bethesda
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
The E14 Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Research Corporation Technologies
North America, Arizona, United States, Tucson
Co-Investments: 1
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 1
BioAdvance
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Blindspot Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Paul McEwan often collaborate with?

JS
North America, California, United States, Santa Barbara
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Paul McEwan?

Volta Labs

Cambridge, Massachusetts, United States

Volta Labs develops scalable automation for genetic engineering.

BiometricsBiotechnologyGenetics
Series AMar 8, 2022
Amount Raised: $20,000,000
Halo Labs

Philadelphia, Pennsylvania, United States

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

AnalyticsBiopharmaBiotechnologyHealth DiagnosticsPharmaceutical
Series BApr 6, 2020
Amount Raised: $12,000,000